Masterbatches provide decorative options for drug delivery devices

Clariant launched new special-effect colors in the MEVOPUR® family of consistent and compliant masterbatches and pre-colored compounds.  By making drug-delivery devices (e.g. pens, inhalers, and the like) more unique and attractive to patients, manufacturers of these products hope to improve patient adherence to treatment.

Several factors combine to increase the importance of using color creatively in the healthcare market, according to Steve Duckworth, Clariant’s Global Head for  Healthcare Polymer Solutions. Diseases such as COPD and diabetes are rapidly increasing and self-administered medication via auto injector or inhaler is becoming the norm, says Mr. Duckworth.  

U.S. studies indicate only 28% patient-adherence to treatment programs. The cost of wasted medication and follow-on treatment  amounts to billions of dollars. Companies are  now looking for ways to make their devices more attractive and easier to use, creating standard ‘device platforms’ that can be customized with color and special effects. Mr. Duckworth added that by making pens and other personal medical devices more like consumer products, patients may be more inclined to carry them and use them.

When added to plastics, special effect pigments create a singular impression like pearlescence, sparkle or a metallic look. These materials have been used for many years to enhance the look and market appeal of personal care and consumer goods, where less regulatory documentation is required. Similar effects have been created using paint and other decorative processes, but these can lack durability, and can severely impact the cost of the plastic component. Special-effect pigments, on the other hand, are compounded into the plastic and cannot chip, scratch or peel off.

Clariant has completed the testing to confirm the ingredients of these new special-effect masterbatches and compounded materials conform to medical and pharmaceutical norms. All products supplied under the MEVOPUR brand are aligned with USP parts 87 and 88 (Class VI devices) and ISO10993. Manufacturing takes place at three ISO 13485 certified and dedicated production facilities located in USA, Europe and Asia. ‘Controlled, Consistent and Compliant’ MEVOPUR materials help manufacturers speed new products to market while supporting their regulatory compliance filings.

The MEVOPUR® special-effect colors for drug delivery devices are being exhibited at the MD&M West 2016, Anaheim, CA (booth #2248), and at Pharmapack Europe 2016 in Paris (stand #430/431). The shows are being held between February 9 and 11.